GlassScriptPhysician profile
Cassandra M List
NPI 1922414499
$154,305.42
in general payments reported to CMS, 2019-2025
14 companies · $46K in 2025
The $46K reported for 2025 was more than what 99% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,706 · 2020: $467 · 2021: $16K · 2022: $31K · 2023: $21K · 2024: $36K · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $63K · Consulting Fee: $22K · Travel and Lodging: $13K · Food and Beverage: $4,603 · Education: $42.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $63,000.00 |
| Consulting Fee | $22,435.00 |
| Travel and Lodging | $12,625.14 |
| Food and Beverage | $4,603.13 |
| Education | $42.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $117,989.50 | 2022-2025 | |
| Allergan, INC. | $23,267.88 | 2019-2022 | |
| Merz Pharmaceuticals, LLC | $6,252.46 | 2021-2025 | Xeomin |
| Medtronic USA, INC. | $2,787.92 | 2019 | |
| Medtronic, INC. | $2,021.41 | 2021-2023 | Synchromedii |
| Merz North America, INC. | $783.15 | 2019-2020 | |
| Saol Therapeutics INC. | $309.49 | 2019-2021 | |
| Ipsen Biopharmaceuticals, INC | $200.37 | 2019 | |
| Penumbra, INC. | $142.39 | 2023 | Red 72 |
| Microtransponder, INC. | $134.78 | 2022 | |
| Piramal Critical Care | $134.62 | 2021-2022 | |
| Spr Therapeutics, INC | $130.14 | 2023 | Sprint Pns System |
| Coloplast Corp | $82.80 | 2022-2024 | Speedicath |
| Amneal Pharmaceuticals LLC | $68.51 | 2023-2024 | Lioresal (Baclofen), Lyvispah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra List listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.